GB1369821A - Pharmaceutical preparations - Google Patents

Pharmaceutical preparations

Info

Publication number
GB1369821A
GB1369821A GB4298371A GB4298371A GB1369821A GB 1369821 A GB1369821 A GB 1369821A GB 4298371 A GB4298371 A GB 4298371A GB 4298371 A GB4298371 A GB 4298371A GB 1369821 A GB1369821 A GB 1369821A
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical preparations
preparations
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4298371A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of GB1369821A publication Critical patent/GB1369821A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB4298371A 1970-10-02 1971-09-15 Pharmaceutical preparations Expired GB1369821A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1461470 1970-10-02

Publications (1)

Publication Number Publication Date
GB1369821A true GB1369821A (en) 1974-10-09

Family

ID=4402343

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4298371A Expired GB1369821A (en) 1970-10-02 1971-09-15 Pharmaceutical preparations

Country Status (10)

Country Link
AU (1) AU464325B2 (en)
BE (1) BE773408A (en)
CA (1) CA960141A (en)
DE (1) DE2147711A1 (en)
ES (1) ES395573A1 (en)
FR (1) FR2112248B1 (en)
GB (1) GB1369821A (en)
IL (1) IL37700A (en)
NL (1) NL7113533A (en)
ZA (1) ZA716148B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ179623A (en) * 1975-01-06 1978-03-06 Ciba Geigy Pharmaceutical preparation containing a beta-receptor blocking compound, a compound regulating thrombocyte function and optionally an alpha-receptor blocking compund

Also Published As

Publication number Publication date
IL37700A (en) 1975-05-22
FR2112248B1 (en) 1975-04-18
AU3405071A (en) 1973-04-05
DE2147711A1 (en) 1972-04-06
CA960141A (en) 1974-12-31
BE773408A (en) 1972-04-04
ZA716148B (en) 1972-05-31
IL37700A0 (en) 1971-11-29
FR2112248A1 (en) 1972-06-16
AU464325B2 (en) 1975-08-21
NL7113533A (en) 1972-04-05
ES395573A1 (en) 1974-12-01

Similar Documents

Publication Publication Date Title
ZA703861B (en) Pharmaceutical preparations
ZA717345B (en) Pharmaceutical preparation
ZA724983B (en) Pharmaceutical preparations
ZA717916B (en) New pharmaceutical preparations
ZA718014B (en) Pharmaceutical formulations
ZA715217B (en) Anti-inflammatory preparations
ZA713877B (en) Pharmaceutical composition
ZA713029B (en) Oral preparations
IL37849A (en) Stable virus preparations
IL40597A0 (en) Antihypertensively pharmaceutical preparations
ZA712472B (en) Pharmaceutical tablet
ZA714076B (en) Pharmaceutical preparation
GB1369821A (en) Pharmaceutical preparations
ZA71609B (en) New pharmaceutical preparations
ZM6571A1 (en) Oral preparations
ZA723920B (en) New pharmaceutical preparations
CA918066A (en) Pharmaceutical preparations
ZA713227B (en) Pharmaceutical preparation
AU3474771A (en) Pharmaceutical preparations
ZA717792B (en) New pharmaceutical preparations
ZA724625B (en) Pharmaceutical preparations
ZA721170B (en) New pharmaceutical preparations
AU447332B2 (en) Pharmaceutical preparations
AU1075770A (en) Therapeutic preparations
ZA714029B (en) Pharmaceutical preparation

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PLNP Patent lapsed through nonpayment of renewal fees